Argenx USA News and Activities

Argenx USA is owned by Argenx.

Argenx is one of the...

• Forbes Global 2000 (#1255);
• Stoxx 600;
• TOB Iconic 10,000.

Argenx is a company listed under the stock ticker ARGX (BE).

Argenx has a direct presence in 2 countries.

View the org chart displaying its 3 main executives

Most searched biographies at Argenx USA

• Cristian Azcarate, Vice President, Patient Strategy & Experience
• Susan Begelman, Vice President, Global Medical Affairs and Evidenc...
• Allen Labrune, Vice President and Head of Patient Support Programs

Popular executive movements at Argenx

• Peter Verhaeghe, Non-executive director and Chairman of the Board, will retire on Mar. 6, 2026  (posted on January 5 2026).
• Tim Van Hauwermeiren who is Chief Executive Officer and Director, will be promoted to Non-Executive Director and Chairman of The Board of Directors on Mar. 6, 2026  (posted on January 5 2026).
• Karen Massey who is Chief Operating Officer, will be promoted to Chief Executive Officer on Mar. 6, 2026  (posted on January 5 2026).

Create your alert
to follow the executive moves at Argenx USA.

Argenx has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Argenx USA

Social media about Argenx USA

• Argenx USA on Wikipedia, Google News & Yahoo Finance
• Argenx USA on LinkedIn, X (Twitter) & YouTube